PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23544168-0	2013	Imatinib and Dasatinib Inhibit Hemangiosarcoma and Implicate PDGFR-beta and Src in Tumor Growth.	Imatinib Mesylate	0-8	SRC proto-oncogene, non-receptor tyrosine kinase	Canis lupus familiaris	76-79	
23544168-4	2013	We report here on the use of the TKIs imatinib and dasatinib in canine hemangiosarcoma and their effects on platelet-derived growth factor receptor beta (PDGFR-beta) and Src inhibition.	Imatinib Mesylate	38-46	SRC proto-oncogene, non-receptor tyrosine kinase	Canis lupus familiaris	170-173